BIND, NephroGenex File for Chapter 11 Bankruptcy Protection - Geneti...
05/02/16
![]()
BIND, NephroGenex File for Chapter 11 Bankruptcy Protection
Genetic Engineering & Biotechnology News
Both BIND and NephroGenex filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. BIND listed estimated assets and liabilities in the range of $10 million to $50 million, while NephroGenex listed total debts of approximately $6 ...
BIND Therapeutics (BIND) Files Chapter 11 BankruptcyStreetInsider.com
BRIEF-NephroGenex files for Chapter 11Reuters
Bind Therapeutics Seeks Chapter 11 Protection After DefaultWall Street Journal
Benzinga -Seeking Alpha -Triangle Business Journal
all 18 news articles »
[more]
Genetic Engineering & Biotechnology News
Both BIND and NephroGenex filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. BIND listed estimated assets and liabilities in the range of $10 million to $50 million, while NephroGenex listed total debts of approximately $6 ...
BIND Therapeutics (BIND) Files Chapter 11 BankruptcyStreetInsider.com
BRIEF-NephroGenex files for Chapter 11Reuters
Bind Therapeutics Seeks Chapter 11 Protection After DefaultWall Street Journal
Benzinga -Seeking Alpha -Triangle Business Journal
all 18 news articles »
- Feeds Categories: